IJR - iShares Core S&P Small-Cap ETF
| Previous Close | 79.06 |
| Open | 79.22 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 78.68 - 79.54 |
| 52 Week Range | 66.77 - 80.68 |
| Volume | 2,228,178 |
| Avg. Volume | 3,558,587 |
| Net Assets | 36.42B |
| NAV | 77.05 |
| PE Ratio (TTM) | N/A |
| Yield | 1.22% |
| YTD Return | 0.57% |
| Beta (3y) | 0.96 |
| Expense Ratio (net) | 0.09% |
| Inception Date | 2000-05-22 |
- Zacks•last month
U.S. Equity Tops Last Week's Asset Flow
The lure for U.S. equity ETFs returned with the record amount of inflows last week.
- Market Realist•2 months ago
Analyzing Flotek Industries’ 4Q17 Performance by Segment
SLCA, FTK, and SPN: Did 4Q17 Earnings Impress Investors?
- ETF Trends•2 months ago
Rising Interest Rates Does Not Spell Doom for Stock ETFs
The Federal Reserve typically hikes interest rates to obviate an overheating economy during the later stages of an economic cycle, typically foreshadowing the eventual end of a bull market. Nevertheless, ...
Market Realist•3 months agoBehind MiMedx Group’s Recent Financial Performance
Why Investors Are Eyeing MiMedx Group Today
- Kiplinger•3 months ago
How to Cash In on Corporate Tax Cuts
Investors can expect higher earnings and more generous dividends.
- Investopedia•3 months ago
Top 3 Small-Cap ETFs for 2018
There's a case to be made that small-cap ETFs will outperform in the months ahead. Here are a few to consider.
Market Realist•3 months agoAnalysts’ Ratings for Nektar Therapeutics in January 2018
A Look at Nektar Therapeutics' Revenue Drivers in 2018Company overview
- Investopedia•5 months ago
Top 3 Small-Cap ETFs for 2017
There's a case to be made that small-cap ETFs will outperform in the final months of 2017. Here are a few to consider.
- Investopedia•6 months ago
Small-Cap ETFs: Better Late Than Never?
Small-cap stocks and ETFs are on a tear, but there are macro issues that could limit near-term upside.
- ETF.com•7 months ago
Active Funds Suddenly Outperforming
The latest SPIVA scorecard shows a large uptick in the number of actively managed funds that are outperforming their benchmarks.
- Investopedia•7 months ago
A Big Battle Among Small-Cap ETFs
One small-cap ETF has been king for a while, but the race for the crown is heating up.
- ETF.com•7 months ago
Least Popular ETFs Of The Year
It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.
- Market Realist•8 months ago
Baxdela Is Expected to Boost Ligand Pharmaceuticals’ Revenues
On June 19, 2017, Melinta Therapeutics announced that its drug, Baxdela, had secured regulatory approval from the FDA as a treatment option for adult patients suffering from acute bacterial skin and skin ...
- Market Realist•8 months ago
Ligand Pharmaceuticals Projects Higher Average Royalty Rate for Promacta
Ligand Pharmaceuticals (LGND) receives royalties from Novartis on Promacta’s sales according to a tiered annual payment structure.
- Market Realist•8 months ago
Analysts’ Recommendations for Ligand Pharmaceuticals and Peers in 2017
In 2Q17, Ligand Pharmaceuticals (LGND) reported revenues of ~$28.0 million, representing year-over-year growth of ~43.4%. LGND received ~$14.2 million in royalties, a year-over-year rise of 45.7%.
- Benzinga•8 months ago
Signs Of A Return To Small-Cap ETFs
One of the most vexing scenarios facing investors this year has been the ongoing disappointment delivered by U.S. small-caps and the corresponding exchange-traded funds. For instance, the iShares Russell ...
- Zacks•8 months ago
Here's Why Small Cap ETFs Are Underperforming
U.S. small cap ETFs suffer on account of growing uncertainty around Trump's pro-growth policies.
- Market Realist•8 months ago
Flotek Industries’ Stock Price Forecast on August 10
Flotek stock will likely close between $6.42 and $5.50 in the next seven days. Flotek's stock price was $5.96 on August 10, 2017.
- Market Realist•8 months ago
A Look at Flotek Industries’ Debt Position in 2Q17
In 2Q17, Flotek Industries’ (FTK) total debt fell ~34% compared to 2Q16.
- Market Realist•8 months ago
What Could Drive Flotek Industries’ Growth?
Flotek Industries’ (FTK) management expressed optimism about improving pricing for FTK’s complex nano-Fluid (or CnF) products despite higher raw material costs.
- Zacks•8 months ago
U.S. Small Business Confidence Up in July: ETFs in Focus
U.S. small business activity improves in July; beats estimates.
- Zacks•9 months ago
ETFs to Buy or Dump Post Upbeat July Jobs Data
July jobs data came in upbeat and put these ETFs in focus.
- Benzinga•9 months ago
Troublesome Signs For Small-Cap ETFs
U.S. small caps have been laggards for essentially all of this year, but the current state of affairs for smaller U.S. stocks is getting downright troubling. While large-cap indexes, such as the Dow Jones ...
